When the B-series compounds were evaluated in the fura-2 assay using STC-1 cells, they were established to be especially weak Ca 2+ elevating agents such that a test concentration of 10 M was necessary to detect any increase of [Ca 2+ ] i (data not shown)
GLP1 injections are commonly used to support weight loss in adults struggling with overweight or obesity
Comparative effectiveness and safety of sodium-glucose cotransporter 2 inhibitors versus glucagon-like peptide 1 receptor agonists in older adults
Glucagon-like peptide 1 receptor agonist (GLP-1 RA): long-term effect on kidney function in patients with type 2 diabetes
The right choice depends on your insurance situation, budget, need for lifestyle support, preference for brand-name versus compounded medications, and how much hand-holding you want from your provider
One large retrospective cohort found that GLP-1 agonist use was associated with a lower risk of pancreatic cancer compared to treatment with other antihyperglycemic drugs, particularly insulin